Veritone (NASDAQ: VERI) launches $50M at-the-market common stock program
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
Veritone, Inc. entered into a sales agreement with UBS Securities, Needham & Company, and Craig-Hallum to sell up to $50.0 million of common stock from time to time in an at-the-market equity offering under its existing Form S-3 shelf registration.
The sales agents will use commercially reasonable efforts to execute sales on The Nasdaq Global Market or other trading venues, for a commission of up to 3.0% of the gross sales price, plus reimbursed expenses. Veritone is not obligated to sell any shares, and the agreement can be terminated by either side on ten days’ notice, upon certain adverse events, or by mutual agreement.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 1.01, 9.01
2 items
Item 1.01
Entry into a Material Definitive Agreement
Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
ATM program size: $50.0 million
Sales agent commission: up to 3.0% of gross sales price
Shelf registration effectiveness date: June 21, 2024
+3 more
6 metrics
ATM program size
$50.0 million
Maximum aggregate offering price of common stock under sales agreement
Sales agent commission
up to 3.0% of gross sales price
Compensation rate payable to sales agents on shares sold
Shelf registration effectiveness date
June 21, 2024
Form S-3 (File No. 333-280148) effectiveness
Prospectus supplement date
May 21, 2026
Date of prospectus supplement governing ATM offering terms
Rule reference
Rule 415(a)(4)
Defines at-the-market equity offering under the Securities Act
Termination notice period
ten days
Advance notice required by either party to terminate the agreement
Key Terms
at-the-market equity offering, Form S-3, prospectus supplement, indemnification and contribution, +1 more
5 terms
at-the-market equity offering financial
"made by any method permitted that is deemed to be an “at-the-market” equity offering as defined in Rule 415(a)(4)"
An at-the-market equity offering is a way for a public company to raise cash by selling newly issued shares directly into the open market at current market prices over time through a broker. Think of it as gradually selling items on an online marketplace at whatever buyers are paying now rather than holding a single big sale; it gives the company flexible access to funds but can lower each existing owner’s share of the company and put gentle downward pressure on the stock price if done in large amounts.
Form S-3 regulatory
"pursuant to the Company’s registration statement on Form S-3 (File No. 333-280148)"
Form S-3 is a legal document companies use to register their stock sales with the government, making it easier and faster for them to raise money by selling shares to investors. It’s like having a pre-approved shopping list that lets a company quickly sell new shares when they need funds, without going through a lengthy approval process each time.
prospectus supplement regulatory
"the related prospectus supplement dated May 21, 2026 (the “Prospectus Supplement”)"
A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.
indemnification and contribution regulatory
"the Company has agreed in the Sales Agreement to provide indemnification and contribution to the Sales Agents against certain liabilities"
Rule 415(a)(4) regulatory
"deemed to be an “at-the-market” equity offering as defined in Rule 415(a)(4) promulgated under the Securities Act"
Rule 415(a)(4) is a U.S. Securities and Exchange Commission rule that lets a company add more securities to an already effective shelf registration, so those additional shares or bonds can be sold later without filing a completely new registration. For investors it matters because it gives the issuer the flexibility to raise cash quickly—like having an open credit line—while creating the possibility of dilution or changes in supply that can affect share price.
FAQ
What did Veritone (VERI) announce regarding new common stock sales?
Veritone entered a sales agreement with UBS Securities, Needham & Company, and Craig-Hallum to sell up to $50.0 million of common stock in an at-the-market equity program under its effective Form S-3 shelf registration and a related May 21, 2026 prospectus supplement.
How will Veritone’s at-the-market offering through VERI stock work?
Veritone may instruct the sales agents to sell common stock from time to time directly on The Nasdaq Global Market or other trading markets. These transactions qualify as an “at-the-market” equity offering under Rule 415(a)(4), allowing flexible, incremental share sales.
What is the maximum amount Veritone (VERI) can raise under this program?
Under the prospectus supplement, Veritone may offer and sell shares of its common stock with an aggregate offering price of up to $50.0 million. Actual proceeds will depend on how many shares the company chooses to sell and the prices obtained.
What fees will Veritone pay the sales agents in this VERI ATM program?
The sales agents are entitled to receive up to 3.0% of the gross sales price of shares sold through them under the agreement. Veritone will also reimburse certain expenses and provide indemnification and contribution against specified liabilities under securities laws.
When did Veritone’s shelf registration for this program become effective?
The at-the-market offering is conducted under Veritone’s existing registration statement on Form S-3 (File No. 333-280148), which became effective on June 21, 2024, and a related prospectus supplement dated May 21, 2026 filed with the SEC.